NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/27/2023
Back to search
Official data from USPTO
TERGUS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TERGUS PHARMA
ST13
US500000085627755Class
5, 42
Filing
85627755
Registration
4463443
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
11/27/2023
Trademark type
Word
Nice classes
5, 42
Filing date
05/17/2012
Registration date
01/07/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/27/2023
Last transaction
11/27/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/31/2012
First use in commerce
08/31/2012
Drawing code
4
Owner type
16
Owner location
Durham, NC, US
Examiner
BLANDU, FLORENTINA
Law office
M80
Current location
TMO LAW OFFICE 117
Holders and representatives
Holders
Tergus Pharma, LLC
Representatives
David D. Postolski Gearhart Law LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsdermatologicals or topicals in the form of semi-solidscreamsoilsointmentsgelslotionsliquidspastesfoamssprays for use in the treatment of skinhairnailsophthalmicoticvaginalskinhairnaileyeearvaginal disorders and/or for delivery through skin into systemic circulation for other disorders; pharmaceutical preparations for topical and transdermal applicationscreamsoilsointmentsgelslotionsliquidspastesfoamssprays for the treatment of skinhairnailsophthalmicoticvaginal and skinhairnaileyeearvaginal disorders
Class 42
Consulting services in the field of clinical drug trialsproduct labeling for pharmaceuticals; pharmaceutical research and development; pharmaceutical product developmentdrug discovery and pharmaceutical researchconducting pharmaceutical clinical trials for others; technological researchearly stage development of innovations and ideas in the nature of new product design and development for othersproduct optimizationproduct research and development for othersprovided to the pharmaceutical industry; pharmaceutical researchdevelopment in the fields of dermatologyskinhairvaginalophthalmicnailsotic and topical drugsmedical and scientific researchconducting clinical trials for others in the fields of dermatologyskinhairvaginalophthalmicnailsotic and topical drugs
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/27/2023
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
11/27/2023
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
11/27/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/27/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
05/31/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/07/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/18/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/18/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/15/2020
E815
TEAS SECTION 8 & 15 RECEIVED
07/07/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/07/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/13/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/13/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
01/07/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/04/2013
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/03/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/01/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/13/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/06/2013
IUAF
USE AMENDMENT FILED
10/03/2013
EISU
TEAS STATEMENT OF USE RECEIVED
10/03/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/13/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/09/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2013
PUBO
PUBLISHED FOR OPPOSITION
02/12/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/23/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/08/2013
ALIE
ASSIGNED TO LIE
01/08/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/18/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2012
GNRT
NON-FINAL ACTION E-MAILED
09/16/2012
CNRT
NON-FINAL ACTION WRITTEN
09/16/2012
DOCK
ASSIGNED TO EXAMINER
09/09/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/22/2012
NWAP
NEW APPLICATION ENTERED
05/21/2012
Continuous trademark protection
Get notified about every new filing that threatens TERGUS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.